Market Overview:
The global diagnostic specialty enzymes market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for accurate and rapid diagnosis, technological advancements in diagnostics, and rising prevalence of chronic diseases. Based on type, the global diagnostic specialty enzymes market is segmented into oxidases, polymerases and nucleases, proteases, and other enzymes. The oxidase segment is expected to account for the largest share of the global diagnostic specialty enzymes market in 2018 owing to its wide applicability in clinical chemistry tests. Based on application, the global diagnostic specialty enzymes market is divided into clinical chemistry, molecular diagnostics immunoassay,, and other applications such as drug discovery & development,. Clinical chemistry held the largest share of this market in 2017 due to its widespread use across hospitals and laboratories for routine testing purposes.
Product Definition:
Diagnostic specialty enzymes are a specific type of enzyme that is used to help diagnose certain medical conditions. These enzymes can be used to help identify the presence of specific proteins or other molecules in the body that may be associated with particular diseases. This information can then be used to help guide treatment decisions.
Oxidases:
Oxidases is a group of enzymes that act on only one substrate at a time. They are found in many organisms and play an important role in the production of vitamins, prostaglandins, and other regulatory hormones. In humans, there are two types: lysosomal and cytosolic oxidases.
Polymerases and Nucleases:
Polymerases and nucleases are enzymes that catalyze the conversion of DNA into RNA, or reversely. These enzymes are used in molecular diagnostics for the detection of genetic diseases. The most common use of polymerase and nucleases is to detect and measure mutations such as those caused by single base pair substitutions (SNPs) or insertions/deletions (INDELs).
Application Insights:
The clinical chemistry segment dominated the global diagnostic specialty enzymes market in 2017. This is owing to factors such as high usage of these tests for the detection of diseases and increasing prevalence of target diseases. For instance, according to a study published by NCBI in 2018, around 1 billion people across the world have diabetes and this number is expected to reach about 2 billion by 2050. Thus, rising incidence rates are anticipated to boost demand for various clinical chemistry tests over the forecast period.
Furthermore, an increase in healthcare spending has resulted in an increased focus on cost-effectiveness through utilization of molecular diagnostics techniques that offer higher accuracy at lesser costs than conventional methods used for diagnosis.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as increasing prevalence of chronic diseases, rising demand for rapid diagnostic tests, and high adoption of advanced technologies. Moreover, presence of key players in this region is expected to drive the growth further. For instance, one of the major players operating in this industry is Thermo Fisher Scientific Inc., which has a strong distribution channel across North America.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as growing target population base and improving healthcare infrastructure with an increase in government spending on diagnostics sector coupled with economic development within countries like India & China & South Korea etc.). In addition, favorable regulatory policies are also anticipated to boost revenue generation from this region during the forecast period.
Growth Factors:
- Increasing demand for early diagnosis of diseases: The global diagnostic specialty enzymes market is expected to grow at a CAGR of 7.5% during the forecast period. This can be attributed to the increasing demand for early diagnosis of diseases, which helps in reducing the mortality rates and improving the quality of life.
- Technological advancements: The development of new technologies has led to the introduction of innovative products in this market, thereby driving its growth. For instance, in 2017, Roche Diagnostics introduced a new test called cobas 8800/8800 system that uses next-generation sequencing (NGS) technology for diagnosing infectious diseases such as tuberculosis (TB) and hepatitis C virus (HCV). This test offers significant advantages over other tests available in the market, such as faster turnaround time and higher accuracy levels.
- Rising prevalence of chronic diseases: The global prevalence of chronic diseases is rising at an alarming rate due to changing lifestyles and environmental factors. This is leading to an increase in demand for diagnostic tests, which is benefiting the growth prospects of this market segmentation.. For instance, according to World Health Organization (WHO), diabetes affected 422 million people worldwide in 2014 and it was estimated that by 2030 this number would reach 642 million people.. Thus, there exists a large potential customer base for diagnostic specialty enzymes manufacturers catering to various segments such as hospitals & clinics laboratories etc., thereby boosting their sales revenues significantly.. 4 Emerging markets offer immense potential:
Scope Of The Report
Report Attributes
Report Details
Report Title
Diagnostic Specialty Enzymes Market Research Report
By Type
Oxidases, Polymerases and Nucleases, Proteases, Other,
By Application
Clinical Chemistry, Molecular Diagnostics, Immunoassay, Others,
By Companies
Roche, Codexis, Amano Enzymes, Biocatalysts, Advanced Enzymes Technologies, Amicogen, Amano Enzymes, Thermo Fisher Scientific, American Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Diagnostic Specialty Enzymes Market Report Segments:
The global Diagnostic Specialty Enzymes market is segmented on the basis of:
Types
Oxidases, Polymerases and Nucleases, Proteases, Other,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Chemistry, Molecular Diagnostics, Immunoassay, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Codexis
- Amano Enzymes
- Biocatalysts
- Advanced Enzymes Technologies
- Amicogen
- Amano Enzymes
- Thermo Fisher Scientific
- American Laboratories
Highlights of The Diagnostic Specialty Enzymes Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oxidases
- Polymerases and Nucleases
- Proteases
- Other
- By Application:
- Clinical Chemistry
- Molecular Diagnostics
- Immunoassay
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diagnostic Specialty Enzymes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diagnostic specialty enzymes are used to identify the presence of specific proteins or other molecules in a sample.
Some of the major companies in the diagnostic specialty enzymes market are Roche, Codexis, Amano Enzymes, Biocatalysts, Advanced Enzymes Technologies, Amicogen, Amano Enzymes, Thermo Fisher Scientific, American Laboratories.
The diagnostic specialty enzymes market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diagnostic Specialty Enzymes Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Diagnostic Specialty Enzymes Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Diagnostic Specialty Enzymes Market - Supply Chain
4.5. Global Diagnostic Specialty Enzymes Market Forecast
4.5.1. Diagnostic Specialty Enzymes Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Diagnostic Specialty Enzymes Market Size (000 Units) and Y-o-Y Growth
4.5.3. Diagnostic Specialty Enzymes Market Absolute $ Opportunity
5. Global Diagnostic Specialty Enzymes Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Diagnostic Specialty Enzymes Market Size and Volume Forecast by Type
5.3.1. Oxidases
5.3.2. Polymerases and Nucleases
5.3.3. Proteases
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Diagnostic Specialty Enzymes Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Diagnostic Specialty Enzymes Market Size and Volume Forecast by Application
6.3.1. Clinical Chemistry
6.3.2. Molecular Diagnostics
6.3.3. Immunoassay
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Diagnostic Specialty Enzymes Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Diagnostic Specialty Enzymes Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Diagnostic Specialty Enzymes Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Diagnostic Specialty Enzymes Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Diagnostic Specialty Enzymes Demand Share Forecast, 2019-2026
9. North America Diagnostic Specialty Enzymes Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Diagnostic Specialty Enzymes Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Diagnostic Specialty Enzymes Market Size and Volume Forecast by Application
9.4.1. Clinical Chemistry
9.4.2. Molecular Diagnostics
9.4.3. Immunoassay
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Diagnostic Specialty Enzymes Market Size and Volume Forecast by Type
9.7.1. Oxidases
9.7.2. Polymerases and Nucleases
9.7.3. Proteases
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Diagnostic Specialty Enzymes Demand Share Forecast, 2019-2026
10. Latin America Diagnostic Specialty Enzymes Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Diagnostic Specialty Enzymes Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Diagnostic Specialty Enzymes Market Size and Volume Forecast by Application
10.4.1. Clinical Chemistry
10.4.2. Molecular Diagnostics
10.4.3. Immunoassay
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Diagnostic Specialty Enzymes Market Size and Volume Forecast by Type
10.7.1. Oxidases
10.7.2. Polymerases and Nucleases
10.7.3. Proteases
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Diagnostic Specialty Enzymes Demand Share Forecast, 2019-2026
11. Europe Diagnostic Specialty Enzymes Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Diagnostic Specialty Enzymes Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Diagnostic Specialty Enzymes Market Size and Volume Forecast by Application
11.4.1. Clinical Chemistry
11.4.2. Molecular Diagnostics
11.4.3. Immunoassay
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Diagnostic Specialty Enzymes Market Size and Volume Forecast by Type
11.7.1. Oxidases
11.7.2. Polymerases and Nucleases
11.7.3. Proteases
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Diagnostic Specialty Enzymes Demand Share, 2019-2026
12. Asia Pacific Diagnostic Specialty Enzymes Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Diagnostic Specialty Enzymes Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Diagnostic Specialty Enzymes Market Size and Volume Forecast by Application
12.4.1. Clinical Chemistry
12.4.2. Molecular Diagnostics
12.4.3. Immunoassay
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Diagnostic Specialty Enzymes Market Size and Volume Forecast by Type
12.7.1. Oxidases
12.7.2. Polymerases and Nucleases
12.7.3. Proteases
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Diagnostic Specialty Enzymes Demand Share, 2019-2026
13. Middle East & Africa Diagnostic Specialty Enzymes Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Diagnostic Specialty Enzymes Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Diagnostic Specialty Enzymes Market Size and Volume Forecast by Application
13.4.1. Clinical Chemistry
13.4.2. Molecular Diagnostics
13.4.3. Immunoassay
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Diagnostic Specialty Enzymes Market Size and Volume Forecast by Type
13.7.1. Oxidases
13.7.2. Polymerases and Nucleases
13.7.3. Proteases
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Diagnostic Specialty Enzymes Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Diagnostic Specialty Enzymes Market: Market Share Analysis
14.2. Diagnostic Specialty Enzymes Distributors and Customers
14.3. Diagnostic Specialty Enzymes Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Codexis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Amano Enzymes
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biocatalysts
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Advanced Enzymes Technologies
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Amicogen
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Amano Enzymes
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Thermo Fisher Scientific
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. American Laboratories
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
